NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...

NIH-Sponsored Trial of Lassa Vaccine Opens - Viral Hemorrhagic Disease Can be Fatal & Causes Permanent Hearing Loss ...

As of February 16, there were 431 cases and 53 deaths in two outbreaks in remote villages in different health zones in ...

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

Known as severe fever with thrombocytopenia syndrome, or SFTS, the highly fatal viral hemorrhagic fever spreads to humans through ixodid ticks, which are typically found in mountains, forests and ...

A renowned virologist and former vice-chancellor of Redeemer’s University, Prof. Oyewale Tomori, has warned that Lassa fever ...

Lassa fever vaccine is one step closer to approval. Lassa virus infections, primarily spread by rodents, can cause a fatal ...

The Nigeria Centre for Disease Control and Prevention (NCDC) has confirmed the death of a 31-year-old physician who recently ...